Consortium advancing cancer prevention and care for people with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535251 · Data updated 2026-11-12
A patient-facing program aims to test new cancer treatments and prevention strategies for people living with HIV, through clinical trials conducted in the U.S. and around the world.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $172,472 |
| NIH project number | 3UM1CA121947-20S3 |
| Project ID | NIH-11535251 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults living with HIV who are at risk for or have AIDS-associated cancers and are eligible for clinical trials.
✕Less likely to help
Some patients may not be eligible for specific trials or may experience side effects from new interventions.
What this research studies
This program runs clinical trials to find better ways to treat and prevent cancers in people with HIV. It also studies how these cancers develop and progress, so care can be tailored to patients’ needs. The network includes multiple sites and scientists who work together to bring new options to patients, with a focus on improving survival and quality of life.
Why it matters
Potential benefit: If successful, it could lead to better cancer outcomes and personalized care for people living with HIV.
How similar studies have gone: The consortium has already conducted many trials and contributed to practice guidelines, showing a track record of progress in this area.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genetically Validated PCOS Subtypes for Better Diagnosis and Risk Stratification
Aimed at women with polycystic ovary syndrome (PCOS), this project uses genetic data and patient characteristics to define distinct PCOS subtypes and improve how we diagnose and estimate risk.
-
Closed-loop control of interneuron timing to influence seizures and memory in epilepsy
A study tests a brain-quieting system that uses light to precisely time certain brain cells in epilepsy-prone mice to see if this can lessen seizures and improve memory.
-
Understanding why some brain regions and cells accumulate tau in Alzheimer’s and related diseases
Researchers are studying why certain brain areas and neuron types accumulate tau protein in Alzheimer’s and related conditions, and how this leads to brain changes and symptoms.
-
Improving blood flow after stroke by breaking down NETs
Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.
-
Aging and brain injury connection: learning how late-life TBI relates to Alzheimer’s and related dementias
This grant looks at whether traumatic brain injuries in people 65 and older are linked to Alzheimer’s disease and related dementias, using a large, harmonized set of long-term aging studies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.